搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
clinicaltrialsarena
18 分钟
Novo Nordisk’s high-dose Wegovy increases weight loss and remains safe
Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.
clinicaltrialsarena
2 天
Palisade Bio begins MAD cohorts of Phase Ia/b ulcerative colitis therapy trial
Palisade Bio has begun the multiple ascending dose (MAD) cohorts of its ongoing Phase Ia/b trial of PALI-2108 for ulcerative ...
clinicaltrialsarena
2 天
Avacta Therapeutics reports data from trial of AVA6000 for salivary gland cancer
Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.
clinicaltrialsarena
3 天
Ocugen doses first subject in Phase I trial of diabetic macular oedema treatment
Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic macular oedema (DMO) treatment.
clinicaltrialsarena
2 天
Boehringer Ingelheim announces Phase III schizophrenia failures
The company said that all of its CONNEX trials failed to meet expectations showing no impact on patients living with ...
clinicaltrialsarena
3 天
European supergroup launches to tackle diversity in clinical trials
The new pan-European group of 73 regulators, companies and trial sites is backed by €66.8m in funding with a six-year goal.
clinicaltrialsarena
4 天
Sen-Jam reports positive outcomes from Phase II trial of Covid-19 therapeutic
Sen-Jam Pharmaceutical has reported positive preliminary outcomes from its Phase II trial of SJP-002C to treat upper ...
clinicaltrialsarena
4 天
Evaxion concludes subject dosing in Phase II trial of melanoma vaccine
Evaxion Biotech has completed subject dosing in the Phase II trial of EVX-01, for the treatment of advanced melanoma.
clinicaltrialsarena
4 天
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole
AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...
clinicaltrialsarena
7 天
Pfizer’s Phase III bladder cancer therapy trial meets primary endpoint
Pfizer's Phase III trial of sasanlimab with BCG in subjects with BCG-naïve, high-risk NMIBC, has met its primary endpoint.
clinicaltrialsarena
4 天
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline
JP Morgan attendees were told of Jazz Pharmaceuticals' plans to expand indications for two oncology drugs: zanidatamab and ...
clinicaltrialsarena
11 天
Insilico announces positive results from Phase I trials of AI-designed ISM5411
ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈